Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CDK9 | P50750 | 10/20 | 0.41 |
| ▸ | CDC7 | O00311 | 2/20 | 0.41 |
| ▸ | PIM1 | P11309 | 1/20 | 0.41 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.36 |
| ▸ | HPGD | P15428 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 1/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.36 |
| ▸ | CCNT1 | O60563 | 8/20 | 0.36 |
| ▸ | OPRL1 | P41146 | 4/20 | 0.36 |
| ▸ | ACHE | P22303 | 1/20 | 0.35 |
| ▸ | GLA | P06280 | 1/20 | 0.33 |
| ▸ | HTT | P42858 | 1/20 | 0.33 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31240799 | 0.80 | CDK9 (0.42) | CDK9CDC7PIM1CYP2D6CCNT1 | |
| SCHEMBL31240504 | 0.79 | DYRK1A (0.40) | CDK9CCNT1 | |
| SCHEMBL31240691 | 0.79 | CDK9 (0.52) | CDK9CDC7PIM1CCNT1 | |
| SCHEMBL31240636 | 0.78 | CDK9 (0.40) | CDK9CDC7PIM1CCNT1 | |
| SCHEMBL26889142 | 0.76 | HTT (0.42) | CDK9CDC7PIM1CYP2D6HPGD | |
| SCHEMBL31240722 | 0.75 | CDK9 (0.56) | CDK9CDC7PIM1CCNT1 | |
| SCHEMBL31240785 | 0.73 | CDK9 (0.47) | CDK9CDC7PIM1CCNT1 | |
| SCHEMBL31240630 | 0.71 | CDC7 (0.52) | CDK9CDC7PIM1 | |
| SCHEMBL16041242 | 0.67 | CSF1R (0.52) | CDK9CCNT1 | |
| SCHEMBL31240664 | 0.65 | CDK9 (0.48) | CDK9CDC7PIM1CCNT1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4705291-A1 | IKK-ALPHA INHIBITORS | Cancer Research Technology Limited (GB) | 2026-03-11 | — | — | EP | disclosed |
| WO-2024228035-A1 | IKK-ALPHA INHIBITORS | CANCER RESEARCH TECHNOLOGY LIMITED (GB) | 2024-11-07 | — | — | WO | disclosed |